참고문헌
- Adami HO, Malker B, Holmberg L, Persson I, Stone B (1986). The relation between survival and age at diagnosis in breast cancer. N Engl J Med, 315, 559-63. https://doi.org/10.1056/NEJM198608283150906
- Anderson BO, Senie RT, Vetto JT, et al (1995). Improved Survival in Young-Women with Breast-Cancer. Ann Sur Oncol, 2, 407-15. https://doi.org/10.1007/BF02306373
- Aebi S, Gelber S, Castiglione-Gertsch M, et al (2000). Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet, 355, 1869-74. https://doi.org/10.1016/S0140-6736(00)02292-3
- Anders CK, Hsu DS, Broadwater G, et al (2008). Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol, 26, 3324-30. https://doi.org/10.1200/JCO.2007.14.2471
- Anders CK, Johnson R, Litton J, Phillips M, Bleyer A (2009). Breast cancer before age 40 years. Semin Oncol, 36, 237-49. https://doi.org/10.1053/j.seminoncol.2009.03.001
- Bantema-Joppe EJ, de Munck L, Visser O, et al (2011). Early-stage young breast cancer patients: impact of local treatment on survival. Int J Radiat Oncol Biol Phys, 81, 553-9.
- Bollet MA, Sigal-Zafrani B, Mazeau V, et al (2007). Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. Radiother Oncol, 82, 272-80. https://doi.org/10.1016/j.radonc.2007.01.001
- Bharat A, Aft RL, Gao F, Margenthaler JA (2009). Patient and tumor characteristics associated with increased mortality in young women (<= 40 years) with breast cancer. J Surg Oncol, 100, 248-51. https://doi.org/10.1002/jso.21268
- Chung M, Chang HR, Bland KI, Wanebo HJ (1996). Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 77, 97-103. https://doi.org/10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3
- Colleoni M, Rotmensz N, Robertson C, et al (2002). Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol, 13, 273-9.
- Chia KS, Du WB, Sankaranarayanan R, et al (2004). Do younger female breast cancer patients have a poorer prognosis? Results from a population-based survival analysis. Int J Cancer, 108, 761-5. https://doi.org/10.1002/ijc.11632
- Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet, 365, 1687-717. https://doi.org/10.1016/S0140-6736(05)66544-0
- Elkum N, Dermime S, Ajarim D, et al (2007). Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer, 7, 222. https://doi.org/10.1186/1471-2407-7-222
- Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, et al (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347, 1233-41. https://doi.org/10.1056/NEJMoa022152
- Foxcroft LM, Evans EB, Porter AJ (2004). The diagnosis of breast cancer in women younger than 40. Breast, 13, 297-306. https://doi.org/10.1016/j.breast.2004.02.012
- Gnerlich JL, Deshpande AD, Jeffe DB, et al (2009). Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg, 3, 341-7.
- Gabriel CA, Domchek SM (2010). Breast cancer in young women. Breast Cancer Res, 12, 212. https://doi.org/10.1186/bcr2647
- Kroman N, Holtveg H, Wohlfahrt J, et al (2004). Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer, 100, 688-93. https://doi.org/10.1002/cncr.20022
- Kim KJ, Huh SJ, Yang JH, et al (2005). Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol, 35, 126-33. https://doi.org/10.1093/jjco/hyi039
- Kimura M, Yanagita Y, Fujisawa T, et al (2007). Study of time course changes in annual recurrence rate for breast cancer. Data analysis of 2209 patients for 10 years post surgery. Breast Cancer Res Treat, 106, 407-11. https://doi.org/10.1007/s10549-007-9510-2
- Kwong A, Cheung P, Chan S, Lau S (2008). Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg, 32, 2554-61. https://doi.org/10.1007/s00268-008-9589-6
- Kheirelseid EH, Boggs JM, Curran C, et al (2011). Younger age as a prognostic indicator in breast cancer: a cohort study. BMC Cancer, 11, 383. https://doi.org/10.1186/1471-2407-11-383
- Khokher S, Qureshi MU, Riaz M, Akhtar N, Saleem A (2012). Clinicopathologic profile of breast cancer patients in Pakistan: ten years data of a local cancer hospital. Asian Pac J Cancer Prev, 13, 693-8. https://doi.org/10.7314/APJCP.2012.13.2.693
- Keramatinia A, Mousavi-Jarrahi SH, Hiteh M, Mosavi-Jarrahi A (2014). Trends in incidence of breast cancer among women under 40 in Asia. Asian Pac J Cancer Prev, 15, 1387-90. https://doi.org/10.7314/APJCP.2014.15.3.1387
- Liede A, Malik IA, Aziz Z, et al (2002). Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan. Am J Hum Genet, 71, 595-606. https://doi.org/10.1086/342506
- Livi L, Meattini I, Saieva C, et al (2010). The impact of young age on breast cancer outcome. Eur J Surg Oncol, 36, 639-45. https://doi.org/10.1016/j.ejso.2010.05.016
- Litiere S, Werutsky G, Fentiman IS, et al (2012). Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol, 13, 412-9. https://doi.org/10.1016/S1470-2045(12)70042-6
- Morales L, Canney P, Dyczka J, et al (2007). European Organisation for Research and Treatment of Cancer Breast Group; Scottish Breast Cancer Trials Group. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group. Eur J Cancer, 43, 331-40. https://doi.org/10.1016/j.ejca.2006.10.009
- Mamoon N, Hassan U, Mushtaq S (2009). Breast carcinoma in young women aged 30 or less in Northern Pakistan - the Armed Forces Institute of Pathology experience. Asian Pac J Cancer Prev, 10, 1079-82.
- Miles RC, Gullerud RE, Lohse CM, et al (2012). Local recurrence after breast conservation surgery: Multivariable analysis of risk factors and the impact of age. Ann Surg Oncol, 19, 1153-9. https://doi.org/10.1245/s10434-011-2084-6
- Memon ZA, Shaikh AN, Rizwan S, Sardar MB (2013). Reasons for patient's delay in diagnosis of breast carcinoma in Pakistan. Asian Pac J Cancer Prev, 14, 7409-14. https://doi.org/10.7314/APJCP.2013.14.12.7409
- Rapiti E, Fioretta G, Verkooijen HM, et al (2005). Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer, 41, 1446-52. https://doi.org/10.1016/j.ejca.2005.02.029
- Sidoni A, Cavaliere A, Bellezza G, Scheibel M, Bucciarelli E (2003). Breast cancer in young women: clinicopathological features and biological specificity. Breast, 12, 247-50. https://doi.org/10.1016/S0960-9776(03)00095-X
- Shaukat U, Ismail M, Mehmood N (2013). Epidemiology, major risk factors and genetic predisposition for breast cancer in the Pakistani population. Asian Pac J Cancer Prev, 14, 5625-9. https://doi.org/10.7314/APJCP.2013.14.10.5625
- Thapa B, Singh Y, Sayami P, et al (2013). Breast cancer in young women from a low risk population in Nepal. Asian Pac J Cancer Prev, 14, 5095-9. https://doi.org/10.7314/APJCP.2013.14.9.5095
- Voogd AC, Nielsen M, Peterse JL, et al (2001). Differences inrisk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol, 19, 1688-97. https://doi.org/10.1200/JCO.2001.19.6.1688
- Vrieling C, Collette L, Fourquet A, et al (2003). EORTC Radiotherapy, Breast Cancer Groups. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer, 39, 932-44. https://doi.org/10.1016/S0959-8049(03)00123-0
- Wei R, Lau SS, Cheung PS (2010). Breast carcinoma in Chinese women: does age affect treatment choice and outcome? Asian J Surg, 33, 97-102. https://doi.org/10.1016/S1015-9584(10)60017-6
- Wang LW, Yang GF, Chen JM, et al (2014). A clinical database of breast cancer patients reveals distinctive clinico-pathological characteristics: a study from central China. Asian Pac J Cancer Prev, 15, 1621-6. https://doi.org/10.7314/APJCP.2014.15.4.1621
피인용 문헌
- Discussing Genetic Testing With Patients With Breast Cancer in Developing Countries: Should We Be Judicious? vol.33, pp.35, 2015, https://doi.org/10.1200/JCO.2015.63.3974